Expert consensus on treating HR+/HER2- metastatic breast cancer based on real-world practice patterns observed in the RETRACT survey of US oncologists

Expert consensus on treating HR+/HER2- metastatic breast cancer based on real-world practice patterns observed in the RETRACT survey of US oncologists

Hormone receptor-positive, HER2-negative metastatic breast cancer (HR+/HER2-mBC) is incurable, but recent progress has been made in developing new treatment options and the treatment landscape is rapidly shifting. There are published recommendations for treatment choices and sequencing to help guide...

Full description

Saved in:
Bibliographic Details
Main Authors: Hope S. Rugo, Aditya Bardia, William J. Gradishar, Erika P. Hamilton, Sara A. Hurvitz, Komal Jhaveri, Reshma Mahtani, Sara M. Tolaney
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:Breast
Subjects:
Metastatic breast cancer
Hormone receptor
Human epidermal growth factor receptor 2
Treatment patterns
Practice guidelines
Side effects
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977625005028
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S0960977625005028

Similar Items